Physician

Mary Anne Depaz, MD

According to 2025 Medicare claims, Mary Depaz, MD (NPI: 1700846664) practices radiation oncology in the Decatur, IL market, with the plurality of this provider's patient population coming from Macon, IL. This provider's primary affiliated billing organization is CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS, S.C. (NPI: 1871580142; TIN: 371160364) and primary practice location at 62526-4163. Depaz is affiliated with the IRCCO (ACO ID: A2619) and SBL accountable care organization (ACO ID: A5147), participating under the MSSP model.

Depaz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 200 traditional Medicare patients, billed 2,238 HCPCS/CPT codes, and received $110,180 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 63 prescription claims across 24 beneficiaries totaling $635 in drug costs. DME data shows 16 claims. Open Payments data shows 112 records totaling $2,197. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $251,888 and ending at $110,180. Concurrently, Part D prescription costs have declined steadily, from $1,909 to $635. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	384	3,684	$251,888
2016	282	3,297	$169,752
2017	312	4,275	$287,484
2018	314	4,727	$223,322
2019	288	3,857	$199,090
2020	272	4,226	$248,913
2021	239	3,100	$144,502
2022	229	3,952	$254,618
2023	207	2,540	$150,313
2024	200	2,238	$110,180

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	37	54	$1,909
2016	34	64	$2,184
2017	38	70	$1,676
2018	22	57	$1,258
2019	33	62	$1,327
2020	27	58	$3,359
2021	16	41	$1,110
2022	22	55	$1,201
2023	15	50	$920
2024	24	63	$635

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	22	$4,832
2024	N/R	16	$3,506

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	62	62	$136
77263	Complex radiation therapy planning	40	42	$129
77334	Design and construction of complex radiation treatment device	41	115	$46
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	110	124	$45
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	102	112	$12

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	16	$3,506

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	112	$2,197	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mary Anne Depaz, MD?

Tedicare shows public-source Medicare data for Mary Anne Depaz, MD (NPI 1700846664), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mary Anne Depaz, MD have ACO affiliation data?

Mary Anne Depaz, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and SBL accountable care organization (MSSP, ACO ID A5147).

What billing organization is linked to Mary Anne Depaz, MD?

Mary Anne Depaz, MD is linked to CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS, S.C. (billing NPI 1871580142) in the available physician profile data.

Does Mary Anne Depaz, MD have Open Payments data?

Mary Anne Depaz, MD has 112 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.